⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6514589 | 1.00 | — | — | |
| SCHEMBL31494789 | 0.73 | — | — | |
| SCHEMBL5773276 | 0.73 | — | — | |
| SCHEMBL2746954 | 0.73 | — | — | |
| SCHEMBL4361943 | 0.69 | — | — | |
| SCHEMBL5071821 | 0.68 | — | — | |
| SCHEMBL6671350 | 0.67 | — | — | |
| SCHEMBL25487800 | 0.65 | — | — | |
| SCHEMBL641605 | 0.65 | — | — | |
| SCHEMBL3055970 | 0.65 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1896404-A1 | PLEUROMUTILIN DERIVATIVES CONTAINING A HYDROXYAMINO- OR ACYLOXYAMINOCYCLOALKYL GROUP | Nabriva Therapeutics Forschungs GmbH (AT) | 2008-03-12 | — | — | EP | claimed |
| WO-2007000004-A1 | PLEUROMUTILIN DERIVATIVES CONTAINING A HYDROXYAMINO- OR ACYLOXYAMINOCYCLOALKYL GROUP | NABRIVA THERAPEUTICS FORSCHUNGS GMBH (AT) | 2007-01-04 | — | — | WO | claimed |
| EP-1896404-A1 | PLEUROMUTILIN DERIVATIVES CONTAINING A HYDROXYAMINO- OR ACYLOXYAMINOCYCLOALKYL GROUP | Nabriva Therapeutics Forschungs GmbH (AT) | 2008-03-12 | — | — | EP | disclosed |
| EP-1809332-A2 | COMPOSITIONS FOR MULTI-STEP DELIVERY OF HOT-SPOTS RADIATION TO CANCER CELLS | Oncologic, Inc. (US) | 2007-07-25 | — | — | EP | disclosed |
| WO-2007000004-A1 | PLEUROMUTILIN DERIVATIVES CONTAINING A HYDROXYAMINO- OR ACYLOXYAMINOCYCLOALKYL GROUP | NABRIVA THERAPEUTICS FORSCHUNGS GMBH (AT) | 2007-01-04 | — | — | WO | disclosed |
| US-20060134124-A1 | Immunosuppression | ML LABORATORIES PLC | 2006-06-22 | — | — | US | disclosed |
| WO-2006010165-A2 | COMPOSITIONS FOR MULTI-STEP DELIVERY OF HOT-SPOTS RADIATION TO CANCER CELLS | ONCOLOGIC, INC. (US) | 2006-01-26 | — | — | WO | disclosed |
| EP-1140153-A2 | IMPROVEMENT OF TOLERANCE TO A XENOGRAFT | ML Laboratories Plc (GB) | 2001-10-10 | — | — | EP | disclosed |
| WO-2000037102-A2 | IMPROVEMENT OF TOLERANCE TO A XENOGRAFT | ML LABORATORIES PLC (GB) | 2000-06-29 | — | — | WO | disclosed |
| WO-1998015572-A1 | A COMPOSITION COMPRISING AN IMMOBILISED, ACYLATED PEPTIDE | AKZO NOBEL N.V. (NL) | 1998-04-16 | — | — | WO | disclosed |